NEW YORK (GenomeWeb) – The University of Pennsylvania Perelman School of Medicine announced that its Basser Center for BRCA has awarded $375,000 in grant funding to support translational breast and ovarian cancer research projects at four US institutes.

The Basser Center, located within Penn's Abramson Cancer Center, was established in 2012 to advance research around cancers associated with BRCA1 and BRCA2 genetic mutations. It received a $5 million donation in 2014 to support an external grants program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Sponsored by

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.